Pharmaceutical

RioDerm-001 by Rion for Diabetic Foot Ulcers: Likelihood of Approval

RioDerm-001 is under clinical development by Rion and currently in Phase II for Diabetic Foot Ulcers.

Feb 20, 2024 - 18:00
RioDerm-001 is under clinical development by Rion and currently in Phase II for Diabetic Foot Ulcers.
Read the original article

Tags:

Previous Article

RioDerm-004 by Rion for Fistula: Likelihood of Approval

Next Article

SY-001 by CellOrigin Technology (Hangzhou) for Solid Tumor: Likelihood of Approval

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

Xcovery edges closer to FDA approval for NSCLC ALK inhibitor

Xcovery edges closer to FDA approval for NSCLC ALK inhi...

Mar 16, 2024

STAT+: Acadia’s Nuplazid fails as treatment for schizophrenia in Phase 3 study

STAT+: Acadia’s Nuplazid fails as treatment for schizop...

Mar 12, 2024

Lotte Knudsen, who pushed Novo Nordisk into the Ozempic era, wins STAT Innovation award

Lotte Knudsen, who pushed Novo Nordisk into the Ozempic...

Oct 18, 2023